Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Shalby Q4 Results: Profit Increases by 19.26% Year Over Year, Live Coverage

Reading Time: < 1 minute

Shalby, a prominent healthcare provider, has recently announced its impressive Q4 results for the year 2024. The company reported a substantial increase in revenue by 22.74% year-over-year, reaching a new high. This growth in revenue showcases Shalby’s strong performance and operational efficiency.

Moreover, the company’s profit also saw a healthy growth of 19.26% compared to the same quarter last year. Despite a slight decrease in profit compared to the previous quarter, Shalby managed to increase its revenue by 13.05%, indicating a positive trend in the company’s financials.

Shalby’s Selling, general & administrative expenses rose by 5.76% quarter-over-quarter but decreased by 4.19% year-over-year, demonstrating effective cost management strategies. The operating income witnessed a significant increase of 81.17% year-over-year, offsetting the decrease from the previous quarter, indicating better operational performance.

The company reported an Earnings Per Share (EPS) of ₹1.49 for Q4, marking a 14.58% increase year-over-year, reflecting positively on the company’s profitability. Despite mixed stock performance results, Shalby continues to be a prominent player in the healthcare sector with a market capitalization of ₹2897.41 Cr.

Analysts covering Shalby have provided positive ratings, with a consensus recommendation of Strong Buy, indicating confidence in the company’s performance. With such strong financial results and market confidence, Shalby is poised for continued success in the healthcare industry. Stay updated on quarterly results with Shalby’s results calendar.

Taylor Swifts New Album Release Health issues from using ACs Boston Marathon 2024 15 Practical Ways To Save Money